CUIMC hosted a mental health awareness event on Oct. 22 for employees to gain understanding and awareness of campus mental health resources during the month of October.

The study presents the first high-resolution 3D structure of an important protein of the malaria parasite, opening new avenues for anti-malarial drug development.

Sadelain was elected for pioneering scientific studies that laid the groundwork for chimeric antigen receptor T cell (CAR-T) immunotherapy for cancer and for advancing its clinical application.

Just five minutes of walking every half hour offsets harmful effects of prolonged sitting, a Columbia University study has found.

Within 3 weeks, mice that received topical ruxolitinib or tofacitinib had regrown nearly all their hair (right photo; drug was applied only to the right side of the mouse). Little to no hair growth ...

New VP&S faculty include a neurologist improving care delivery for patients with epilepsy and a radiologist investigating the treatment of metastatic cancers in the liver with radioembolization.

Drugs already in development may have the potential to block the chemical and help people exposed to trauma in childhood, who do not often respond to SSRIs.

James McKiernan, senior vice dean for clinical affairs and CEO of ColumbiaDoctors, who served as interim VP&S dean for most of the 2024-2025 fiscal year, spoke about the resilience of faculty during a ...

View the CUIMC Update, a weekly e-newsletter featuring medical center news and the accomplishments of our faculty, staff, and trainees.

Read previous issues of CUIMC Update.View the CUIMC Update, a weekly e-newsletter featuring medical center news and the accomplishments of our faculty, staff, and trainees.